OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Heart-Healthy and Stroke-Free World
George A. Mensah, Valentı́n Fuster, Gregory A. Roth
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 25, pp. 2343-2349
Open Access | Times Cited: 78

Showing 51-75 of 78 citing articles:

[Latest Findings on the Role of α-Ketoglutarate in Metabolic Syndrome].
Yuhan Li, Yuan Wang, Quan Yuan
PubMed (2024) Vol. 55, Iss. 3, pp. 783-792
Closed Access

Bridging the Gap
Cathleen Biga
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 8, pp. 761-763
Closed Access

Low-Molecular-Weight Compounds Produced by the Intestinal Microbiota and Cardiovascular Disease
Lorena Cuervo, Patrick L. McAlpine, Carlos Olano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10397-10397
Open Access

The RAAS system SNPs polymorphism is associated with essential hypertension risk in rural areas in northern China
Cheng Jin, Jing Cui, Yuanyuan Li, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 14, pp. 2694-2704
Open Access

Analysis of the Predictors of Mortality from Ischemic Heart Diseases in the Southern Region of Brazil: A Geographic Machine-Learning-Based Study
Amanda de Carvalho Dutra, Lincoln Silva, Isadora Martins Borba, et al.
Global Heart (2024) Vol. 19, Iss. 1
Open Access

Impacto do uso da semaglutida nos parâmetros cardiometabólicos de pacientes obesos não diabéticos: uma revisão sistemática
Letícia Sayuri Sasaki, Felipe Goes Costa, Altair Gustavo Saura Martins, et al.
Cuadernos de Educación y Desarrollo (2024) Vol. 16, Iss. 13, pp. e6745-e6745
Open Access

Metabolites of Microbiota: A Novel Therapy for Heart Disease
Fei Yao, Chao Liu, D. W. Luo, et al.
Food Reviews International (2024), pp. 1-17
Closed Access

Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches
Xiaoyang Zhou, Hao Wang, Biao Yan, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access

Associations between plasma caspase-1 levels and cardiovascular disease, and the mediating role of metabolic syndrome: Findings from the UK Biobank
Yajuan Zhang, Yumei Huang, Shaobo Hu, et al.
Atherosclerosis (2024) Vol. 401, pp. 119090-119090
Closed Access

Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)
Yikuan Du, Mengting Zhang, Ziyi Luo, et al.
Expert Opinion on Drug Safety (2024), pp. 1-8
Closed Access

Research Progress on Residual Cholesterol and Cardiovascular Disease Risk
安岑 唐
Advances in Clinical Medicine (2024) Vol. 14, Iss. 12, pp. 1228-1233
Closed Access

Editor-in-Chief’s Top Picks From 2023
Valentı́n Fuster
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 10, pp. 961-1026
Open Access

Progress in Chinese medicine monomers and their nanoformulations on myocardial ischemia/reperfusion injury
Yanrong Zhou, Li Wang, Lina Sun, et al.
Journal of Materials Chemistry B (2024)
Closed Access

Scroll to top